Cyprus vs Saudi Arabia: Proportion of bloodstream infection due to methicillin-resistant
Cyprus
53.0%
in 2023
Saudi Arabia
49.5%
in 2023
Cyprus rank
11th
Saudi Arabia rank
13th
Proportion of bloodstream infection due to methicillin-resistant over time
- Cyprus
- Saudi Arabia
How they compare
Cyprus currently reports 53.0% against 49.5% in Saudi Arabia, a difference of 3.5%.
That makes Cyprus's figure about 1.1 times Saudi Arabia's.
The two have swapped places 3 times across 7 shared years of data; in 2017 it was Saudi Arabia ahead.
Cyprus ranks 11th and Saudi Arabia ranks 13th of 55 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.1% | 42.8% | 14.3% | Cyprus |
| 2020s | 50.4% | 50.3% | 0.1% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Cyprus or Saudi Arabia?
- Cyprus, at 53.0% against 49.5% in Saudi Arabia as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Cyprus and Saudi Arabia?
- 3.5%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Saudi Arabia?
- 7 years are reported by both, from 2017 to 2023.
- How do Cyprus and Saudi Arabia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Cyprus ranks 11th and Saudi Arabia ranks 13th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.